Publications - AmberGen

Publications and Posters

How can MSI enhance our understanding of ASO distribution?

January 1, 2025 • van der Vloet, L., Hilaire, P. B. S., Bouillod, C., Isin, E. M., Heeren, R. M. A., & Vandenbosch, M. (2025). In Drug Discovery Today ...

Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease

September 18, 2024 • Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma

Gel-assisted mass spectrometry imaging enables sub-micrometer spatial lipidomics

June 12, 2024 • Chan, Y. H., Pathmasiri, K. C., Pierre-Jacques, D., Hibbard, M. C., Tao, N., Fischer, J. L., Yang, E., Cologna, S. M., & Gao, R. (2024). In Nature Communications (Vol. 15, Issue 1). Springer Science and Business Media LLC. • Multiomic, GAMSI, Expansion-Microscopy, Lipids, Proteins

Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response

May 29, 2024 • Pearce, S.M.; Cross, N.A.; Smith, D.P.; Clench, M.R.; Flint, L.E.; Hamm, G.; Goodwin, R.; Langridge, J.I.; Claude, E.; Cole, L.M. Metabolites 2024, 14, 315. • Drug study, Multiomic, Multimodal, Tumor Spheroids

Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma

February 25, 2024 • Stillger, M. N., Li, M. J., Hönscheid, P., von Neubeck, C., & Föll, M. C. (2024). In PROTEOMICS (Vol. 24, Issues 12–13). Wiley. • Multiomic and Multimodal techniques

Technology Spotlight: Advances in Proteomic Technologies and Their Applications in Hematology

January 17, 2024 • Mangalaparthi, K. K., & Pandey, A. (2024). In The Hematologist (Vol. 21, Issue 1). American Society of Hematology. • Review Article